F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 172,320 shares at $26.28 ($4.5M) on 2023-04-11, disclosed to the SEC on 2023-04-13.
Open-market sale of $4.5M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.28 | 44,764 | $1.2M | 26.0% |
| 2 | $26.28 | 44,764 | $1.2M | 26.0% |
| 3 | $27.28 | 5,026 | $137K | 3.0% |
| 4 | $27.28 | 5,026 | $137K | 3.0% |
| 5 | $26.12 | 36,370 | $950K | 21.0% |
| 6 | $26.12 | 36,370 |
| $950K |
| 21.0% |
| Total | $26.27 avg | 172,320 | $4.5M | 100% |
| Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |
| TMCI | SELL | 2023-02-23 | $615K | — | Filing → |